The ACA New Member Bundle offers accredited continuing education credit for pharmacists and pharmacy technicians, totaling 3 hours (0.3 CEUs). This bundle includes three informative webinars.

The first webinar, Legal Insights into Peptide & Semaglutide Compounding: Navigating FDA, State Boards, and Telemedicine, by Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA, Senior Counsel, Frier Levitt, and Matthew J. Modafferi, Esq., Partner, Frier Levitt, provides an overview of the evolving legal and regulatory landscape, including Sections 503A and 503B, FDA guidance, enforcement trends, and telemedicine considerations.

The second webinar, DSCSA – 13 Year Implementation & 2024 Update, by Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA, reviews DSCSA requirements and prepares pharmacies for the November 2026 enforcement, including electronic data exchange, verification, and audit readiness.

The third webinar, Conquer Your Personal Coliseum by Developing Your Inner Gladiator, by Jay Phipps, PharmD, MBA, FACA, FACVP, focuses on building resilience, overcoming challenges, and developing practical strategies for personal and professional growth.

Shortly after joining ACA, new members will receive a “Welcome Email” containing a code for complimentary access to the ACA New Member Bundle. Current members and non-members can also purchase the bundle at https://www.lecturepanda.com/a/NewMember

Earn 1 hour (0.1 CEU) of continuing education credit with the on-demand webinar, Legal Insights into GLP-1 and Peptide Compounding in 2026: FDA and Private Enforcement, State Board Compliance, and the Future of Telehealth Prescribing.

As the regulatory environment for compounded GLP-1s and peptides continues to shift, pharmacy professionals must stay informed on new enforcement trends and compliance expectations. This session provides a practical overview of the legal and regulatory landscape impacting 503A pharmacies, 503B outsourcing facilities, and telehealth providers.

Our expert speakers review key topics including FDA enforcement actions, State Board of Pharmacy oversight, and private litigation involving compounded GLP-1 products. The webinar also explores the impact of the end of GLP-1 shortages, current prescribing and compounding practices, and evolving risks related to telehealth and marketing activities.

Participants will gain a clearer understanding of compliance considerations, enforcement trends, and risk mitigation strategies to support safe and compliant pharmacy operations in this rapidly changing area.

Watch our on-demand webinar, Methylene Blue and Clinical Opportunities and earn 1 hour (0.1 CEU) of accredited continuing education designed for pharmacy professionals.

As interest grows around the clinical use of methylene blue, pharmacy professionals are encountering new therapeutic possibilities across infectious disease, neurology, anti-aging, and mitochondrial health. This program provides a clear overview of methylene blue’s evolving role in practice, including recent research on conditions such as Lyme disease, dementia, Alzheimer’s disease, COVID-19, recurrent UTIs, and chronic inflammatory syndromes. You will explore methylene blue’s mechanisms of action, including its antioxidant effects, influence on mitochondrial energy production, and potential nootropic benefits.

The session also reviews key pharmacology, dosing considerations, safety parameters, contraindications, and adverse effects. Practical guidance for working with methylene blue in the compounding lab is included, offering tips to reduce contamination, manage staining, and improve workflow efficiency.

Earn 1 hour (0.1 CEU) of continuing education credit with the on-demand webinar, What You Must Know About LDN (Low Dose Naltrexone).

As interest in Low Dose Naltrexone (LDN) continues to rise, pharmacy professionals are seeking clear guidance on how this therapy fits into modern patient care. This session provides a practical, clinically focused overview of LDN—explaining how its pharmacology and mechanisms differ from standard-dose naltrexone and why those differences matter in chronic pain, autoimmune disease, and neuroinflammatory conditions.

You’ll explore evidence supporting LDN’s use in fibromyalgia, neuropathic pain, migraines, multiple sclerosis, Hashimoto’s thyroiditis, inflammatory bowel disease, and other emerging indications. The presentation also covers counseling strategies, titration methods, potential side effects, and key considerations when preparing LDN in a compounding pharmacy.

With insights that bridge research and real-world practice, this webinar is designed to help pharmacists and technicians better support individualized therapy, strengthen patient education, and navigate the growing clinical demand for LDN.

Earn 1 hour (0.1 CEU) of accredited CE with the on-demand webinar, Conquer Your Personal Coliseum by Developing Your Inner Gladiator, created for pharmacy professionals. In healthcare, personal growth is just as important as clinical and business skills. This webinar helps pharmacists and pharmacy technicians build resilience, set meaningful goals, and grow both personally and professionally.

What You’ll Learn:

• How to overcome common challenges to personal growth
• Simple strategies for setting and achieving goals
• Tools to create a personal growth plan

By the end, you’ll feel more confident as a leader, team member, and patient care provider. Watch now and start building your “inner gladiator”!

Our on-demand webinar, Understanding Adrenal Fatigue offers 1 hour (0.1 CEU) of accredited continuing education specifically tailored for pharmacy professionals. This session highlights the crucial role pharmacists play in recognizing and managing adrenal health. Adrenal fatigue is often overlooked and can range from normal function to serious conditions like Addison’s disease. Many patients fall in between, with symptoms that are easy to miss.

The webinar will cover key signs of adrenal insufficiency and explain the roles of hormones like adrenaline, hydrocortisone, and progesterone. You’ll learn to identify subtle signs of adrenal dysfunction and gain practical tools for effective management. With this knowledge, you can better support your patients and improve their long-term health outcomes.

Free for ACA Fellows through June 30, 2026.

Earn 1 hour (0.1 CEU) of accredited CE with the on-demand webinar, Legal Insights into Peptide & Semaglutide Compounding: Navigating FDA, State Boards, and Telemedicine, created for pharmacy professionals.

As peptide and semaglutide compounding continues to evolve, pharmacy professionals face new legal challenges and opportunities. This session will explain the latest updates and regulations in this area. Our expert speakers will discuss important topics like the FDA’s stance on peptide compounding, recent changes from state Boards of Pharmacy, and legal issues with brand manufacturers.

The webinar will also explore the growing role of telemedicine and how it affects compounding, with tips on handling bulk chemical ingredients. Register now to stay updated, ensure compliance, and improve your practice while better supporting your patients.

Watch our on-demand webinar, DSCSA: 13-Year Implementation & 2024 Update and earn 1 hour (0.1 CEU) of accredited continuing education designed for pharmacy professionals. Learn about the DSCSA’s 13-year implementation journey and get the latest updates for 2024 and beyond in this 1-hour accredited CE webinar (0.1 CEUs) for Pharmacists and Pharmacy Technicians.

This session covers key DSCSA requirements for transaction information and statements, steps to implement package-level electronic traceability, compliance strategies for audits and regulatory requests, and best practices for handling suspect products. With the FDA enforcement deadline set for November 27, 2026, it’s crucial to start preparing now.

Earn up to 3 hours (0.3 CEUs) of continuing education designed to help pharmacists and pharmacy technicians navigate and apply current USP compounding standards in pharmacy practice. This bundle, presented by subject matter experts, provides practical guidance on both sterile and nonsterile compounding, veterinary compounding regulations, and interpreting official USP monographs.

The first webinar, “GFI #256: How It Affects Compounding for Veterinary Patients” by Brenda Jensen, CPhT, CNMT, MBA (0.5 CE), helps veterinary compounders understand FDA Guidance for Industry #256. This session outlines when enforcement discretion may be applied, how to nominate bulk drug substances for office stock, and how to stay compliant when compounding animal medications in today’s regulatory environment.

The second webinar, “Understanding the Revision to USP <795> Pharmaceutical Compounding – Nonsterile Preparations” by Brenda Jensen, CPhT, CNMT, MBA (0.5 CE), prepares attendees for updates taking effect November 1, 2023. Learn how to identify eligible nonsterile dosage forms, assign appropriate beyond-use dates, and implement revised standards for facilities, personnel, and documentation.

In the third webinar, “Preparing for Change: Key Aspects of Revised USP <797> Pharmaceutical Compounding – Sterile Preparations” by Brenda Jensen, CPhT, CNMT, MBA (1 CE), participants will review major changes related to Category 1, 2, and 3 sterile preparations. Topics include environmental monitoring, personnel competency, facility requirements, and quality management practices.

The final webinar, “Interpreting and Applying USP Compounded Preparation Monographs in Pharmacy Practice: Recipes for Quality” by Gigi Davidson, BSPharm, DICVP, FACVP, FSVHP (1 CE), provides a deep dive into USP Compounded Preparation Monographs (CPMs). Learn how to locate, interpret, and apply these standardized “recipes” to improve consistency and quality in compounded medications, especially in veterinary settings.